Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives

SIMPLE SUMMARY: Immune checkpoint inhibitors represent a promising treatment choice in many kind of tumours, including hepatocellular carcinoma (HCC). In this review, we provide an overview of the role of these new agents in the management of HCC according to the Barcelona staging system, alongside...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Federico, Piera, Petrillo, Angelica, Giordano, Pasqualina, Bosso, Davide, Fabbrocini, Antonietta, Ottaviano, Margaret, Rosanova, Mario, Silvestri, Antonia, Tufo, Andrea, Cozzolino, Antonio, Daniele, Bruno
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7603151/
https://ncbi.nlm.nih.gov/pubmed/33080958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12103025
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky